ReviewStroke2026
Targeting Brain Networks for Recovery: Multimodal Innovations in Poststroke Therapy.
Review in Stroke, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Neuroimmune regulation of post-traumatic bone regeneration: focus on inflammatory switching and functional recovery.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Stroke disrupts brain networks across multiple spatiotemporal scales, producing structural and functional deficits that extend beyond focal injury. Peri-infarct networks are particularly vulnerable yet provide a foundation for neurological recovery driven by neuroplasticity mechanisms, including synaptic remodeling, axonal sprouting, and neuronal network reorganization. This review highlights emerging therapeutic strategies aimed at targeting these networks. Nanomedicine, biomaterials, and biologically driven systems enable the precise delivery of agents, neurotrophic factors, and genetic modulators to enhance and induce plasticity. In parallel, noninvasive neuro-stimulation approaches offer complementary, network-specific modulation that can be synergized with drugs or biomaterial platforms. Finally, advances in artificial intelligence and machine learning are driving precision, feedback-driven interventions that align therapeutics with the dynamic trajectory of poststroke network reorganization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.